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Introduction
Acute biliary infection is a systemic infectious disease 
which requires prompt treatment and has a signiﬁ  cant 
mortality rate.1 The ﬁ  rst report on acute biliary infec-
tion was Charcot’s “The symptoms of hepatic fever” in 
1877.2
This section of the Tokyo Guidelines deﬁ  nes acute 
cholangitis and acute cholecystitis, and describes the 
incidence, etiology, pathophysiology, classiﬁ  cation, and 
prognosis of these diseases.
Acute cholangitis
Deﬁ  nition
Acute cholangitis is a morbid condition with acute 
inﬂ  ammation and infection in the bile duct.
Historical aspects of terminology
Hepatic fever. “Hepatic fever” was a term used for the 
ﬁ  rst time by Charcot,2 in his report published in 1877. 
Intermittent fever accompanied by chills, right upper 
quadrant pain, and jaundice became known as Char-
cot’s triad.
Abstract
This article discusses the deﬁ  nitions, pathophysiology, and 
epidemiology of acute cholangitis and cholecystitis. Acute 
cholangitis and cholecystitis mostly originate from stones in 
the bile ducts and gallbladder. Acute cholecystitis also has 
other causes, such as ischemia; chemicals that enter biliary 
secretions; motility disorders associated with drugs; infections 
with microorganisms, protozoa, and parasites; collagen dis-
ease; and allergic reactions. Acute acalculous cholecystitis is 
associated with a recent operation, trauma, burns, multisys-
tem organ failure, and parenteral nutrition. Factors associated 
with the onset of cholelithiasis include obesity, age, and drugs 
such as oral contraceptives. The reported mortality of less 
than 10% for acute cholecystitis gives an impression that it is 
not a fatal disease, except for the elderly and/or patients with 
acalculous disease. However, there are reports of high mor-
tality for cholangitis, although the mortality differs greatly 
depending on the year of the report and the severity of the 
disease. Even reports published in and after the 1980s indicate 
high mortality, ranging from 10% to 30% in the patients, with 
multiorgan failure as a major cause of death. Because many 
of the reports on acute cholecystitis and cholangitis use differ-
ent standards, comparisons are difﬁ  cult. Variations in treat-
ment and risk factors inﬂ  uencing the mortality rates indicate 
the necessity for standardized diagnostic, treatment, and 
severity assessment criteria.
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Acute obstructive cholangitis. Acute obstructive cholan-
gitis was deﬁ  ned by Reynolds and Dargan3 in 1959 as a 
syndrome consisting of lethargy or mental confusion 
and shock, as well as fever, jaundice, and abdominal 
pain, caused by biliary obstruction. They indicated that 
emergent surgical biliary decompression was the only 
effective procedure for treating the disease. These ﬁ  ve 
symptoms were then called Reynolds’s pentad.
Longmire’s classiﬁ  cation.4 Longmire classiﬁ  ed patients 
with the three characteristics of intermittent fever ac-
companied by chills and shivering, right upper quadrant 
pain, and jaundice as having acute suppurative cholan-
gitis. Patients with lethargy or mental confusion and 
shock, along with the triad, were classiﬁ  ed as having 
acute obstructive suppurative cholangitis (AOSC). He 
also reported that the latter corresponded to the mor-
bidity of acute obstructive cholangitis as deﬁ  ned by 
Reynolds and Dargan,3 and he classiﬁ  ed acute microbial 
cholangitis as follows:
1.    Acute cholangitis developing from acute 
cholecystitis
2. Acute non-suppurative  cholangitis
3. Acute suppurative  cholangitis
4.  Acute obstructive suppurative cholangitis
5.    Acute suppurative cholangitis accompanied by 
hepatic abscess.
Incidence
Etiology
Acute cholangitis requires the presence of two factors: 
(1) biliary obstruction and (2) bacterial growth in bile 
(bile infection). Frequent causes of biliary obstruction 
are choledocholithiasis, benign biliary stenosis, stricture 
of a biliary anastomosis, and stenosis caused by malig-
nant disease (level 4).5,6 Choledocholithiasis used to be 
the most frequent cause of the obstruction, but recently, 
the incidence of acute cholangitis caused by malignant 
disease, sclerosing cholangitis, and non-surgical instru-
mentation of the biliary tract has been increasing. It is 
reported that malignant disease accounts for about 
10%–30% of cases of acute cholangitis. Tables 1 and 2 
show some results of studies on the causes of acute 
cholangitis.
Risk factors. The bile of healthy subjects is generally 
aseptic. However, bile culture is positive for microor-
ganisms in 16% of patients undergoing a non-biliary 
operation, in 72% of acute cholangitis patients, in 44% 
of chronic cholangitis patients, and in 50% of those with 
biliary obstruction (level 4).12 Bacteria in bile are identi-
ﬁ  ed in 90% of patients with choledocholithiasis accom-
panied by jaundice (level 4).13 Patients with incomplete 
Table 1.  Etiology of acute cholangitis
Cholelithiasis
Benign biliary stricture
Congenital factors
Postoperative factors (damaged bile duct, strictured 
choledojejunostomy, etc.)
Inﬂ  ammatory factors (oriental cholangitis, etc.)
Malignant occlusion
  Bile duct tumor
  Gallbladder tumor
  Ampullary tumor
  Pancreatic tumor
Duodenal tumor
Pancreatitis
Entry of parasites into the bile ducts
External pressure
Fibrosis of the papilla
Duodenal diverticulum
Blood clot
Sump syndrome after biliary enteric anastomosis
Iatrogenic factors
Table 2.  Causes of acute cholangitis (%)
  Causes
        GB Benign  Malignant  Sclerosing  Others/
Author Year  Setting  N  stones stenosis  stenosis  cholangitis  unknown
Gigot6  1963–1983 University  of  Paris  412  48%  28%  11%    1.5%  —
Saharia and Cameron7  1952–1974 Johns  Hopkins    76  70%  13%  17%    0%  —
      Hospital, USA
Pitt and Couse8  1976–1978 Johns  Hopkins    40  70%  18%  10%    3%  —
      Hospital, USA
Pitt and Couse8  1983–1985 Johns  Hopkins    48  32%  14%  30%  24%  —
      Hospital, USA
Thompson9  1986–1989 Johns  Hopkins    96  28%  12%  57%    3%  —
      Hospital, USA
Basoli10  1960–1985 University  of  Rome    80  69%  16%  13%    0%  4%
Daida11  1979 Questionnaire  throughout  472  56%    5%  36%  —  3%
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obstruction of the bile duct present a higher positive 
bile culture rate than those with complete obstruction 
of the bile duct. Risk factors for bactobilia include vari-
ous factors, as described above.14
Post-endoscopic retrograde cholangiopancreatography 
(ERCP) infectious complications.  The incidence of 
complications after ERCP ranges from 0.8% to 12.1%, 
though it differs depending on the year of the report 
and the deﬁ  nition of complications (level 4).15–23 Overall 
post-ERCP mortality is reported to be between 0.5% 
and 1.5% (level 4).18 The most frequent complication is 
acute pancreatitis, but it is usually mild or moderate. 
Table 3 shows the reported incidence of various post-
ERCP complications.
The incidences of post-ERCP acute cholangitis and 
cholecystitis are, as shown in Table 3, 0.5%–1.7% and 
0.2%–0.5%, respectively.15–19 The complications caused 
by ERCP performed for diagnostic and for therapeutic 
purposes are different. Therapeutic ERCP tends to 
cause all complications, including cholangitis, more fre-
quently than diagnostic ERCP.17,20
The increasing use of ERCP and the improved opera-
tors’ skills and techniques in recent years have reduced 
the incidence of post-ERCP complications, although 
the incidence of acute cholecystitis has not dropped and 
seems unpredictable.17
Other etiologies of acute cholangitis. There are two 
other etiologies of acute cholangitis; Mirizzi syndrome 
and lemmel syndrome. Mirizzi syndrome is a morbid 
condition with stenosis of the common bile duct caused 
by mechanical pressure and/or inﬂ  ammatory changes 
caused by the presence of stones in the gallbladder 
neck and cystic ducts.24 Two types have been described: 
type I, which is a morbid condition with the bile duct 
compressed from the left by the presence of stones in 
the gallbladder neck and cystic ducts and pericholecys-
tic inﬂ  ammatory changes; and type II, which is a morbid 
condition with biliobilary ﬁ  stulation caused by pressure 
necrosis of the bile duct due to cholecystolithiasis.
Lemmel syndrome is a series of morbid conditions in 
which the duodenal parapapillary diverticulum com-
presses or displaces the opening of the bile duct or 
pancreatic duct and obstructs the passage of bile in the 
bile duct or hepatic duct, thereby causing cholestasis, 
jaundice, gallstone, cholangitis, and pancreatitis.25
Pathophysiology
The onset of acute cholangitis involves two factors: (i) 
increased bacteria in the bile duct, and (ii) elevated in-
traductal pressure in the bile duct that allows transloca-
tion of bacteria or endotoxins into the vascular system 
(cholangio-venous reﬂ  ux). Because of its anatomical 
characteristics, the biliary system is likely to be affected 
by elevated intraductal pressure. In acute cholangitis, 
with the elevated intraductal biliary pressure, the bile 
ductules tend to become more permeable to the trans-
location of bacteria and toxins. This process results in 
serious infections that can be fatal, such as hepatic 
abscess and sepsis.
Prognosis
Patients who show early signs of multiple organ failure 
(renal failure, disseminated intravascular coagulation 
[DIC], alterations in the level of consciousness, and 
shock) as well as evidence of acute cholangitis (fever 
accompanied by chills and shivering, jaundice, and ab-
dominal pain), and who do not respond to conservative 
treatment, should receive systemic antibiotics and un-
dergo emergent biliary drainage.1 We have to keep in 
mind that unless early and appropriate biliary drainage 
is performed and systemic antibiotics are administered, 
death will occur.
The reported mortality of acute cholangitis varies 
from 2.5% to 65%26–37  (Table 4). The mortality rate 
before 1980 was 50%,26,27 and after 1980 it was 10%–
30%.28–37  Such differences in mortality are probably 
attributable to differences in early diagnosis and im-
proved supportive treatment.
The major cause of death in acute cholangitis is mul-
tiple organ failure with irreversible shock, and mortality 
rates have not signiﬁ  cantly improved over the years.26–33 
Causes of death in patients who survive the acute stage 
of cholangitis include multiple organ failure, heart fail-
ure, and pneumonia.34
Acute cholecystitis
Deﬁ  nition
Acute cholecystitis is an acute inﬂ  ammatory disease of 
the gallbladder. It is often attributable to gallstones, but 
many factors, such as ischemia; motility disorders; direct 
chemical injury; infections with microorganisms, proto-
zoa, and parasites; collagen disease; and allergic reac-
tion are involved.
Incidence
Acute cholecystitis cases account for 3%–10% of all 
patients with abdominal pain.38–40  The percentage of 
acute cholecystitis cases in patients under 50 years old 
with abdominal pain (n  =  6317) was low, at 6.3%, 
whereas that in patients aged 50 and over (n = 2406) 
was high, at 20.9% (average, 10%)40 (Table 5).
Etiology
Cholecystolithiasis accounts for 90%–95% of all causes 
of acute cholecystitis, while acalculous cholecystitis 
accounts for the remaining 5%–10% (level 4).41–4718  Y. Kimura et al.: Deﬁ  nition, pathophysiology, and epidemiology of cholangitis and cholecystitis
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Table 4.  Mortality of acute cholangitis
Author Period  Country  No.  of  subjects  Mortality  (%)
Andrew26  1957–1967 USA    17c  64.71
Shimada27  1975–1981 Japan    42b  57.1
Csendes28  1980–1988 Chile  512  11.91
Himal and Lindsac29  1980–1989 Canada    61  18.03
Chijiiwa30  1980–1993 Japan    27c  11.11
Liu31  1982–1987 Taiwan    47a  27.66
Lai32  1984–1988 Hong  Kong    86b  19.77
Thompson33  1984–1988 USA  127    3.94
Arima34  1984–1992 Japan  163    2.45
Kunisaki35  1984–1994 Japan    82  10.98
Tai36  1986–1987 Taiwan  225    6.67
Thompson37  1986–1989  USA   96   5.21
a Only patients with shock
b Only severe cases
c Only AOSC
Table 5.  Acute cholecystitis in patients with abdominal pain
Reports of all patients with abdominal pain
  Telfer40
  Eskelinen et al.38  Brewer et al.39  Under 50  50 years and
 n  = 1333  n = 1000 years  old  (n = 6317) over  (n = 2406)
Nonspeciﬁ  c 618  Unknown  cause  413  Nonspeciﬁ  c 39.5%  Acute  cholecystitis  20.9%
  abdominal pain          abdominal pain
Appendicitis 271  Gastroenteritis    69  Appendicitis  32.0%  Nonspeciﬁ  c 15.7%
              abdominal pain
Acute cholecystitis  124  Intrapelvic    67  Acute cholecystitis    6.3%  Appendicitis  15.2%
      infection
Ileus   53  Urinary tract   52  Ileus   2.5%  Ileus  12.3%
      infection
Dyspepsia   50  Ureterolith   43  Acute  hepatitis   1.6%  Acute hepatitis   7.3%
Ureterolith   57  Appendicitis    43  Diverticulitis  <0.1% Diverticulitis    5.5%
Diverticulitis   19  Acute  cholecystitis    25  Cancer  <0.1% Cancer    4.1%
Mesenteric   11  Ileus    25  Hernia  <0.1% Hernia    3.1%
  lymphadenitis
Acute pancreatitis   22  Constipation    23  Vascular lesion  <0.1% Vascular  lesion    2.3%
Peptic  ulcer    9  Duodenal  ulcer   20
  perforation
Urinary tract    22  Dysmenorrhea    18
  infection
Gynecological   15  Pregnancy    18
  diseases
Others   62  Pyelitis   17
    Gastritis   14
    Chronic   12
      cholecystitis
    Ovarian abscess    10
    Dyspepsia   10
Risk factors. Acute cholecystitis is the most frequent 
complication occurring in patients with cholelithiasis. 
According to the Comprehensive Survey of Living Con-
ditions of the People on Health and Welfare conducted 
by the Medical Statistics Bureau of the Japanese Min-
istry of Health and Welfare, the number of those with 
acute cholecystitis has increased, from 3.9 million in 
1979 to over 10 million in 1993 (Public Welfare Index 
in Japan; 1933; level 4).
According to the review by Friedman,48 of the natural 
history of cholelithiasis, serious symptoms or com-
plications (acute cholecystitis, acute cholangitis, clinical 20  Y. Kimura et al.: Deﬁ  nition, pathophysiology, and epidemiology of cholangitis and cholecystitis
jaundice, and pancreatitis) were observed in 1%–2% of 
asymptomatic patients and in 1%–3% of patients with 
mild symptoms per year (Table 6), and the risk of com-
plications increased in the ﬁ  rst several years after the 
discovery of gallbladder stones, but then decreased 
(level 2c). Every year, 6%–8% of patients whose symp-
toms progress from minor to serious undergo cholecys-
tectomy, but this percentage decreases year by year.48
In a follow-up of cholelithiasis patients with mild or 
nonspeciﬁ  c symptoms (n = 153), acute gallstone compli-
cation was observed in 15% (n = 23) and acute chole-
cystitis was seen in 12% (n = 18) (level 4).49 According 
to another report, on the follow-up of the patients with 
asymptomatic cholelithiasis (n = 600), 16% (96) of them 
presented with some symptoms (average period of 
observation until the manifestation of symptom, 29.8 
months) during the follow-up period, while 3.8% (23 
patients) presented with acute cholecystitis. The rate of 
change from asymptomatic to symptomatic cholelithia-
sis is highest during the ﬁ  rst 3 years after diagnosis 
(15%–26%), but then declines (level 4). However, there 
is a report suggesting that there is no difference in the 
incidence of common symptoms such as heartburn and 
upper abdominal pain, in cholelithiasis patients between 
those patients with asymptomatic cholelithiasis and 
controls without gallstones (level 2b).50
AIDS as a risk factor. Enlarged liver and/or abnormal 
liver functions are observed in two/thirds of AIDS 
patients, some of whom have biliary tract disease. 
Biliary disease may occur by two mechanisms in AIDS 
patients: via AIDS cholangiopathy (which is more fre-
quent) and via acute acalculous cholecystitis; AIDS 
patients with sclerosing cholangitis are also seen.
AIDS cholangiopathy is often observed in middle-
aged male patients who have had AIDS for more than 
1 year (average disease period, 15 ± 2.2 months; average 
age, 37 years [range, 21 to 59 years]). Ninety percent of 
the patients complain of upper abdominal pain and 
have enlarged intra- and extrahepatic bile ducts on ab-
dominal ultrasonography. Abnormal ﬁ  ndings on ab-
dominal ultrasonography and computed tomography 
are seen in 81% and 78% of patients, respectively. Bio-
chemical tests show a marked increase in the level of 
alkaline phosphatase (level 4).51
Acalculous cholecystitis in AIDS patients is charac-
terized by: (1) younger age than in non-AIDS patients, 
(2) problems with oral ingestion (3), right upper ab-
dominal pain, (4) a marked increase in alkaline phos-
phatase and a mild increase in serum bilirubin level, and 
(5) association with cytomegalovirus and cryptosporid-
ium infections (level 4).51 According to a review of ab-
dominal surgery for AIDS patients, acute cholecystitis 
is the most frequent reason for performing open surgery 
in AIDS patients.52
Drugs as etiologic agents. According to the review by 
Michielsen et al.,53 regarding the association between 
drugs and acute cholecystitis, 90%–95% of acute chole-
cystitis cases are caused by cholelithiasis, and drugs pro-
moting the formation of stones are indirectly associated 
with a risk of acute cholecystitis (level 4). The etiologi-
cal mechanism of drug-associated gallbladder diseases, 
as discussed in the review,53 is shown in Table 7.
Table 6.  Natural history of asymptomatic, mildly symptomatic, and symptomatic cholelithiasis patients
      Average    Only those with
      follow-up No.  of  acute  remarkable
    No. of  period  cholecystitis  jaundice      Gallbladder
Author Characteristic  cases  (years)  cases  (%)  (%)  Cholangitis  Cholecystitis  cancer
Comfort et al.  Asymptomatic  112  15    0   0  0   0  0
Lund  Asymptomatic   95  13   ?    ?  1  (?)    0  0
Gracie et al.  Asymptomatic  123  11    2   0  0   1  0
McSherry et al.  Asymptomatic  135    5    3   0  0   0  0
Friedman et al.  Asymptomatic  123    7    4   2  2   0  0
Thistle et al.  Asymptomatic  305    2  ≥3   0  0    0  0
   + Symptomatic
Wenckert et al.  Mildly  781  11  81 (10.4)  <59a  0  <59a 3
    symptomatic
Ralston et al.  Mildly  116  22    ?    ?  ?    ?  2
    symptomatic
Friedman et al.  Mildly  344    9 20  (5.8)    10  1    3  2
    symptomatic
Newman et al.  Symptomatic  332  10  38 (11.4)    ?  ?    1  2
McSherry et al.  Symptomatic  556    7 47  (8.5)    19  0    0  1
Review by Friedman48
a In this report, 59 cases were diagnosed as jaundice and/or acute pancreatitis, based on serum bilirubin and amylase valuesY. Kimura et al.: Deﬁ  nition, pathophysiology, and epidemiology of cholangitis and cholecystitis  21
It is reported that women taking oral conceptives 
have a higher risk of having gallbladder disease, but 
there also is a report which denies the association be-
tween the disease and these drugs (level 2a).54 Among 
various drugs used for the treatment of hyperlipidemia, 
only ﬁ  brate is shown to be associated with gallstone 
diseases (level 2b).55 One report suggests that thiazides 
induce acute cholecystitis (level 3b),56 and another re-
port denies this association (level 3b).57 The administra-
tion of a large dose of ceftriaxone, a third-generation 
cephalosporin antimicrobial, in infants, precipitates cal-
cium salt in bile and forms a sludge in 25%–45% of 
them, but these effects disappear when the medication 
is discontinued (level 4).53 It is reported that the long-
term administration of octreotide causes cholestasis, 
and that administration for a year causes cholelithiasis 
in 50% of patients (level 4).53 Hepatic artery infusion 
will cause chemical cholecystitis (level 4).53  Erythr-
omycin and ampicillin are reported to be a cause of 
hypersensitive cholecystitis (level 4).53 According to a 
meta-analysis of the risk of disease induced by hormone 
replacement therapy, the relative risks (RRs) of chole-
cystitis were 1.8 (95% conﬁ  dence interval [CI], 1.6–2.0) 
and 2.5 (95% CI, 2.0–2.9) at less than 5 years of 
treatment and at 5 and more years, respectively 
(level 1a).58
Ascaris as an etiologic factor. The complications of as-
cariasis include hepatic, biliary, and pancreatic diseases. 
Complications in the biliary tract include: (1) choleli-
thiasis with the ascarid as a nidus for stone formation, 
(2) acalculous cholecystitis (3), acute cholangitis (4), 
acute pancreatitis, and (5) hepatic abscess.59  Biliary 
tract disease is caused by the obstruction of the hepatic 
and biliary tracts by the entry of ascarids from the duo-
denum through the papilla. Ascarids entering the biliary 
tract usually return to the duodenum in a week, but if 
they stay over 10 days there, they will die and form a 
nidus for stone formation.
Ascarid-associated biliary diseases occur more fre-
quently in women (male/female ratio, 1 : 3) and less fre-
quently in infants. The risk of biliary complications is 
higher in pregnant than in non-pregnant women (level 
4).59 In epidemic regions such as China and Southeast 
Asia, ascariasis is a frequent cause of cholelithiasis.59
Role of pregnancy. The risk of cholelithiasis in women 
begins to increase when adolescence begins and it de-
clines when the menopause begins. It is also said that 
the use of oral conceptives is correlated with a risk of 
gallbladder disease. It is considered, therefore, that 
levels of estrogen and progesterone are involved in the 
formation of gallstones.60  Cholecystitis is the second 
most common cause of acute abdomen, following ap-
pendicitis, in pregnant women, and occurs in one of 
1600 to 10 000 pregnant women (level 4).60 Cholelithia-
sis is the most frequent cause of cholecystitis in preg-
nancy and accounts for 90% or more of all causes of 
cholecystitis (level 4).60 Routine ultrasonography found 
cholelithiasis in 3.5% of pregnant women (level 4),60 but 
it is unknown whether pregnancy increases the risk of 
cholecystitis. The frequency of cholecystectomy in preg-
nant women is lower than that in non-pregnant women. 
This is not because of the lower incidence of cholecys-
tectomy in pregnant women, but because physicians 
tend to refrain from performing any operation during 
pregnancy. Though there are few reports of patients 
undergoing cholecystectomy during pregnancy, there is 
no evidence that laparoscopic surgery increases the 
maternal or fetal risks (level 2c).61
Acute cholecystitis and four (or ﬁ  ve) “Fs”. It has been 
said that the patients with cholelithiasis have factors 
such as “4F” and “5F” (fair, fat, female, fertile, and 
Table 7.  Etiological mechanisms of gallbladder diseases
Etiological mechanism  Drug/Treatment
Direct chemical toxicity  Hepatic artery infusion
Promotion of stone formation by bile
Inhibition of ACAT activity  Progesterone, ﬁ  brate
Increased hepatic lipoprotein receptors  Estrogen
Induction of acute cholecystitis in patients  Thiazides (unconﬁ  rmed)
  with cholelithiasis
Promotion of calcium salt precipitation in bile  Ceftriaxone octreotide
Altered mobility of the gallbladder  Narcoid
  Anticholinergic drugs
Promotion of hemolysis  Dapsone
Immunological mechanism  Antimicrobial drugs (erythromycin,
    ampicillin)
  Immunotherapy
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forty). Common to all individuals with these “4/5Fs” are 
high levels of estrogen and progesterone.
According to the Framingham Study, which exam-
ined the risk factors for cholelithiasis in a 10-year 
follow-up study of 30- to 59-year-old subjects, the risk 
of cholelithiasis within 10 years was highest among the 
55- to 62-year-old age group, and most of the patients 
were diagnosed with cholelithiasis in their ﬁ  fties and 
sixties. Although the incidence of cholelithiasis in fe-
male patients of all age groups is more than double that 
of male patients, the difference between the incidence 
in men and women tends to shrink with increasing age 
(level 1b).62
Cholelithiasis is one of the main diseases associated 
with obesity. The Framingham study also conﬁ  rms that 
cholelithiasis patients tend to be more obese than non-
cholelithiasis patients (level 2a).62 However, there is a 
report that this tendency is much more prominent in 
female than in male patients.63 Not only obesity but also 
dieting is associated with the risk of cholelithiasis. Dras-
tic dieting increases the risk of cholelithiasis in obese 
people (level 2b).64–67 The incidences of both cholelithia-
sis and cholecystitis in obese people (age, 37–60 years; 
women with a body mass index [BMI] of 34 or higher 
and men with a BMI of 38 or more) are signiﬁ  cantly 
higher that those in non-obese people (cholelithiasis, 
5.8% vs 1.5%; Odds ratio [OR], 4.9; women 6.4% vs 
22.6%; OR, 4.7; cholecystitis, 0.8% vs 3.4%; OR, 5.2; 
women 4.0% vs 11.2%; OR, 3.4) (level 2b).68
The Framingham Study indicates that the number of 
pregnancies in those patients who had cholelithiasis at 
entry into a cohort or those in whom the symptoms of 
cholelithiasis appeared within 10 years, was signiﬁ  cantly 
higher than the number of pregnancies in subjects not 
fulﬁ  lling these criteria (level 2b).62
Though the association of “4F” and “5F” with chole-
lithiasis has been relatively closely examined, no study 
has examined the association of factors other than 
obesity and age with the risk of onset of acute 
cholecystitis.
Pathophysiology
In the majority of patients, gallstones are the cause of 
acute cholecystitis. The process is one of physical ob-
struction of the gallbladder by a gallstone, at the neck 
or in the cystic duct. This obstruction results in increased 
pressure in the gallbladder. There are two factors which 
determine the progression to acute cholecystitis — the 
degree of obstruction and the duration of the obstruc-
tion. If the obstruction is partial and of short duration 
the patient experiences biliary colic. If the obstruction 
is complete and of long duration the patient develops 
acute cholecystitis. If the patient does not receive early 
treatment, the disease becomes more serious and com-
plications occur.
Pathological classiﬁ  cation
Edematous cholecystitis: ﬁ  rst stage (2–4 days). The gall-
bladder has interstitial ﬂ  uid with dilated capillaries and 
lymphatics. The gallbladder wall is edematous. The gall-
bladder tissue is intact histologically, with edema in the 
subserosal layer.
Necrotizing cholecystitis: second stage (3–5 days). The 
gallbladder has edematous changes with areas of hem-
orrhage and necrosis. When the gallbladder wall is sub-
jected to elevated internal pressure, the blood ﬂ  ow is 
obstructed, with histological evidence of vascular throm-
bosis and occlusion. There are areas of scattered necro-
sis, but it is superﬁ  cial and does not involve the full 
thickness of the gallbladder wall.
Suppurative cholecystitis: third stage (7–10 days). The 
gallbladder wall has white blood cells present, with ar-
eas of necrosis and suppuration. In this stage, the active 
repair process of inﬂ  ammation is evident. The enlarged 
gallbladder begins to contract and the wall is thickened 
due to ﬁ  brous proliferation. Intrawall abscesses are 
present and involve the entire thickness of the wall. 
Pericholecystic abscesses are present.
Chronic cholecystitis. Chronic cholecystitis occurs after 
the repeated occurrence of mild attacks of cholecystitis, 
and is characterized by mucosal atrophy and ﬁ  brosis of 
the gallbladder wall. It can also be caused by chronic 
irritation by large gallstones and may often induce acute 
cholecystitis.
Speciﬁ  c forms of acute cholecystitis.  There are four 
speciﬁ  c forms of acute cholecystitis: (1) acalculous cho-
lecystitis, which is acute cholecystitis without cholecys-
tolithiasis; (2) xanthogranulomatous cholecystitis, which 
is characterized by the xanthogranulomatous thicken-
ing of the gallbladder wall and elevated intra-gallblad-
der pressure due to stones, with rupture of the the 
Rokitansky-Achoff sinuses. This rupture causes leakage 
and bile entry into the gallbladder wall. The bile is in-
gested by histocytes, forming granulomas consisting of 
foamy histocytes. Patients usually have symptoms of 
acute cholecystitis in the initial stage. (3) emphysema-
tous cholecystitis, in which air appears in the gallblad-
der wall due to infection with gas-forming anaerobes, 
including Clostridium perfringens. This form is likely to 
progress to sepsis and gangrenous cholecystitis; it is of-
ten seen in diabetic patients. (4) Torsion of the gallblad-
der.69 Torsion of the gallbladder is known to occur by 
inherent, acquired, and other physical causes. An inher-
ent factor is a ﬂ  oating gallbladder, which is very mobile 
because the gallbladder and cystic ducts are connected 
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clude splanchnoptosis, senile humpback, scoliosis, and 
weight loss. Physical factors causing torsion of the gall-
bladder include sudden changes of intraperitoneal pres-
sure, sudden changes of body position, a pendulum-like 
movement in the anteﬂ  exion position, hyperperistalsis 
of organs near the gallbladder, defecation, and trauma 
to the abdomen.
Incidence of complications with advanced forms of 
acute cholecystitis
The incidence of complications with advanced forms of 
acute cholecystitis ranges widely, from 7.2% to 26%, in 
reports published since 1990.70–74 In patients with acute 
cholecystitis (n = 368), the incidence of morbidity was 
17%, with the incidences of gangrenous, suppurative, 
perforating, and emphysematous cholecystitis being 
7.1%, 6.3%, 3.3%, and 0.5%, respectively.74
Types of complications. There are four types of compli-
cations. (1) Perforation of the gallbladder, which is 
caused by acute cholecystitis, injury, or tumors, and oc-
curs most often as a result of ischemia and necrosis of 
the gallbladder wall. (2) Biliary peritonitis, which occurs 
with the entry into the peritoneal cavity of bile leaked 
due to various causes, including cholecystitis-induced 
gallbladder perforation, trauma, a catheter detached 
during biliary drainage, and incomplete suture after bili-
ary operation. (3) Pericholecystic abscess, a morbid 
condition in which a perforation of the gallbladder wall 
is covered by the surrounding tissue, with the formation 
of an abscess around the gallbladder. (4) Biliary ﬁ  stula, 
which can occur between the gallbladder and the duo-
denum following an episode of acute cholecystitis. The 
ﬁ  stula is usually caused by a large gallbladder stone 
eroding through the wall of the gallbladder into the 
duodenum. If the stone is large, the patient can develop 
gallstone ileus, with the stone causing mechanical small-
bowel obstruction at the ileocecal valve.
Prognosis
The mortality in patients with acute cholecystitis is 
0–10%75–81 (Table 8), whereas the mortality in patients 
with postoperative cholecystitis and acalculous chole-
cystitis is as high as 23%–40%.82–84  The mortality of 
elderly patients (75 years and older) tends to be higher 
than that of younger patients,85,86  and a comorbidity 
such as diabetes may increase the risk of death.75 
Many reports of the mortality and morbidity of 
acute cholecystitis are difﬁ  cult to compare, because 
there are signiﬁ  cant variations in the diagnostic criteria, 
timing and type of operation, presence of comor  bidities, 
and hospital support systems for critically ill patients, 
as well as variations in available surgical expertise.
According to reports published in 1980 and before, 
most of the causes of death after cholecystectomy were 
related to postoperative infections, such as ascending 
cholangitis, hepatic abscess, and sepsis.76,77 Since 1980, 
postoperative mortality from infection has decreased 
and the major causes of death include myocardial in-
farction, cardiac failure, and pulmonary infarction.78,79 
Cholecystostomy was a common form of treatment in 
1970 and before, and the most common cause of death 
during that period was pneumonia and sepsis.87  Cur-
rently, the major causes of death following cholecystos-
tomy include malignant tumor, respiratory failure, and 
cardiac failure.88,89
Recurrence rate of acute cholecystitis after 
conservative treatment
Most patients with acute cholecystitis are treated with 
a cholecystectomy, and it is difﬁ  cult to anticipate wheth-
er the outcome will show recurrence. Recurrences of 
clinical concern include the recurrence of (1) acute cho-
lecystitis after spontaneous recovery without the under-
going of any treatment; (2) acute cholecystitis while 
waiting for cholecystectomy after conservative treat-
ment with diet modiﬁ  cation and antibiotics; (3) acute 
Table 8.  Mortality of acute cholecystitis
Author  Period  Country  Subjects  No. of cases  Mortality (%)
Meyer76  1958–1964 USA      245    4.49
Ranasohoff75  1960–1981 USA      298    3.36
Gagic77  1966–1971  USA      93   9.68
Girard and Moria78  1970–1986 Canada   1691    0.65
Addison and Finan79  1971–1990 UK      236    4.66
Bedirli80  1991–1994 Turkey     368    2.72
Gharaibeh81  1993–1900 Jordan      204    0
Haﬁ  f85  1952–1967  Israel  Age, 70 years and older    131    3.82
Gingrich87  1976–1985  USA  Only external biliary drainage    114  32
Glenn86  1977–1987  USA  Age, 65 years old and older    655    9.92
Kalliafas82  1981–1987  USA  Acalculous cases only      27  40.74
Inoue and Mishima83  1989–1993  Japan  Postoperative cases only    494  23.08
Savoca84  1994–1999  USA  Acalculous  cases  only    47   6.3824  Y. Kimura et al.: Deﬁ  nition, pathophysiology, and epidemiology of cholangitis and cholecystitis
cholecystitis when cholecystectomy is not performed for 
some reason, such as surgical risk or the patient’s deci-
sion (with or without biliary drainage); and (4) cholan-
gitis after cholecystectomy.
There are no data on the recurrence of acute chole-
cystitis after resolution of the initial symptoms. The re-
currence of acute cholecystitis while patients are waiting 
for cholecystectomy following conservative treatment 
ranges from 2.5% to 22%.75,90 In 311 patients with acute 
calculous cholecystitis , 25 of 39 patients who did not 
have a cholecystectomy during the acute stage were 
scheduled to undergo delayed operation after being dis-
charged from hospital. Only 1 of the 25 patients (2.5%) 
developed recurrent acute cholecystitis while waiting 
for an operation.75 In non-severe cases, acute cholecys-
titis recurred in 2% of patients within an 8- to 10-week 
waiting period, 6% of whom showed gallbladder 
perforation.90
Long-term recurrence is reported to be 10%–50% in 
6 months to several years of observation, though there 
are few reports. According to a randomized controlled 
trial comparing non-operative treatment and cholecys-
tectomy for patients with acute cholecystitis, excluding 
those with severe cases (n = 56), 11% had a history of 
acute cholecystitis, and 8 (24%) of 33 patients assigned 
to non-operative treatment underwent cholecystectomy 
during an observation period of 1.5–4 years.91 In pa-
tients with acute cholecystitis who were observed after 
treatment with percutaneous drainage, acute cholecys-
titis recurred once or more in 28 of 60 patients (47%) 
during an average observation period of 18 months,88 
and it recurred once or more in 11 of 36 (31%) patients 
who were observed for 37 months on average.89 In a 
report of 114 patients who underwent only cholecystos-
tomy, among 585 patients who were hospitalized be-
cause of acute cholecystitis, acute cholecystitis recurred 
in 5 of 23 patients observed for 6 months to 14 years 
and 14 of the 23 patients remained asymptomatic.92
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